Compositions For Continuous Administration Of Dopa Decarboxylase Inhibitors

Patent No. EP2432454 (titled "Compositions For Continuous Administration Of Dopa Decarboxylase Inhibitors") was filed by Neuroderm on May 17, 2010. The application was issued on Mar 1, 2017.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
TEVA PHARMACEUTICALS	Nov 29, 2017	GREINER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Dec 10, 2019
Communication to the parties concerning termination of the opposition proceedings - opposition rejected - no appeal lodged
Dec 10, 2019
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Dec 5, 2019
Termination of the opposition proceedings with maintenance of patent
Oct 1, 2019
Advice of delivery
Oct 1, 2019
Communication about missing advice of delivery
Aug 28, 2019
Advice of delivery
Aug 26, 2019
Acknowledgement of a document
Aug 26, 2019
Acknowledgement of a document
Aug 26, 2019
Decision of the Opposition Division and instruction
Aug 26, 2019
Decision rejecting the opposition
Aug 26, 2019
Grounds for the decision (Annex) - opposition
Aug 26, 2019
Internal form - Opposition/addressees
Aug 26, 2019
Means of redress
Jul 11, 2019
Advice of delivery
Jul 8, 2019
Brief communication - Opposition proceedings
Jul 4, 2019
Advice of delivery
Jul 4, 2019
Brief communication - Opposition proceedings
Jul 4, 2019
Communication of amended entries
Jul 4, 2019
Notification concerning the date of oral proceedings
Jul 4, 2019
Notification concerning the date of oral proceedings
Jul 2, 2019
Written submission in preparation to/during oral proceedings
Jun 26, 2019
Authorisation
Jun 26, 2019
Request concerning representative opponent
May 17, 2019
Brief communication - Opposition proceedings
May 15, 2019
Brief communication - Opposition proceedings
May 10, 2019
Brief communication - Opposition proceedings
May 9, 2019
(Electronic) Receipt
May 9, 2019
Citation in opposition procedure
May 9, 2019
Citation in opposition procedure
May 9, 2019
Citation in opposition procedure
May 9, 2019
Citation in opposition procedure
May 9, 2019
Citation in opposition procedure
May 9, 2019
Citation in opposition procedure
May 9, 2019
Claims
May 9, 2019
Claims
May 9, 2019
Claims
May 9, 2019
Claims
May 9, 2019
Letter accompanying subsequently filed items
May 9, 2019
Non-patent literature cited during the opposition procedure
May 9, 2019
Non-patent literature cited during the opposition procedure
May 9, 2019
Non-patent literature cited during the opposition procedure
May 9, 2019
Non-patent literature cited during the opposition procedure
May 9, 2019
Non-patent literature cited during the opposition procedure
May 9, 2019
Non-patent literature cited during the opposition procedure
May 9, 2019
Written submission in preparation to/during oral proceedings
May 7, 2019
(Electronic) Receipt
May 7, 2019
Letter accompanying subsequently filed items
May 7, 2019
Request for interpreters during oral proceedings
Jan 22, 2019
Advice of delivery
Jan 21, 2019
Advice of delivery
Dec 19, 2018
Advice of delivery
Dec 13, 2018
Acknowledgement of a document
Dec 13, 2018
Acknowledgement of a document
Dec 13, 2018
Annex to the communication - opposition
Dec 13, 2018
Information concerning oral proceedings
Dec 13, 2018
Summons to attend oral proceedings
Dec 13, 2018
Summons to attend oral proceedings
May 11, 2018
Brief communication - Opposition proceedings
Apr 25, 2018
(Electronic) Receipt
Apr 25, 2018
Citation in opposition procedure
Apr 25, 2018
Letter accompanying subsequently filed items
Apr 25, 2018
Non-patent literature cited during the opposition procedure
Apr 25, 2018
Non-patent literature cited during the opposition procedure
Apr 25, 2018
Reply of the patent proprietor to the notice(s) of opposition
Mar 21, 2018
Brief communication - Opposition proceedings
Mar 20, 2018
Communication of amended entries
Mar 13, 2018
(Electronic) Receipt
Mar 13, 2018
Authorisation
Mar 13, 2018
Letter accompanying subsequently filed items
Mar 13, 2018
Request for change of opponent's representative
Jan 30, 2018
Brief communication - Opposition proceedings
Jan 30, 2018
Communication of amended entries
Jan 30, 2018
Notification of termination of representative's authorisation
Jan 24, 2018
(Electronic) Receipt
Jan 24, 2018
Letter accompanying subsequently filed items
Jan 24, 2018
Request for change of opponent's representative
Dec 15, 2017
Communication of a notice of opposition and request to file observations
Dec 15, 2017
Notice of further oppositions to opponent(s)
Dec 7, 2017
Communication of a notice of opposition - first information to patent proprietor
Nov 29, 2017
(Electronic) Receipt
Nov 29, 2017
Citation in opposition procedure
Nov 29, 2017
Citation in opposition procedure
Nov 29, 2017
Non-patent literature cited during the opposition procedure
Nov 29, 2017
Notice of opposition
Nov 29, 2017
Notice of opposition
Nov 29, 2017
Patent document cited during the opposition procedure
Nov 29, 2017
Patent document cited during the opposition procedure
Nov 29, 2017
Patent document cited during the opposition procedure
Mar 1, 2017
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Feb 2, 2017
Decision to grant a European patent
Jan 10, 2017
(Electronic) Receipt
Jan 10, 2017
Filing of the translations of the claims
Jan 10, 2017
French translation of claims
Jan 10, 2017
German translation of the claims
Jan 10, 2017
Letter accompanying subsequently filed items
Sep 16, 2016
Bibliographic data of the European patent application
Sep 16, 2016
Communication about intention to grant a European patent
Sep 16, 2016
Intention to grant (signatures)
Sep 16, 2016
Text intended for grant (clean copy)
Sep 16, 2016
Text intended for grant (version for approval)
Aug 12, 2016
Letter which had not been notified
Jul 22, 2016
(Electronic) Receipt
Jul 22, 2016
Amended claims with annotations
Jul 22, 2016
Amended description with annotations
Jul 22, 2016
Claims
Jul 22, 2016
Description
Jul 22, 2016
Letter accompanying subsequently filed items
Jul 22, 2016
Reply to communication from the Examining Division
Jun 3, 2016
Annex to the communication
Jun 3, 2016
Consultation by telephone/in person (with time limit)
Jun 3, 2016
Result of consultation by telephone/in person
Mar 18, 2016
Communication concerning the filing of a power of attorney
Mar 18, 2016
Communication of amended entries concerning the representative
Mar 16, 2016
(Electronic) Receipt
Mar 16, 2016
Letter accompanying subsequently filed items
Mar 16, 2016
Reply to communication from the Examining Division
Mar 16, 2016
Reply to communication from the Examining Division
Mar 16, 2016
Reply to communication from the Examining Division
Mar 1, 2016
(Electronic) Receipt
Mar 1, 2016
Authorisation
Mar 1, 2016
Letter accompanying subsequently filed items
Mar 1, 2016
Submission concerning change of applicant's representative
Nov 19, 2015
Annex to the communication
Nov 19, 2015
Communication from the Examining Division
Aug 28, 2015
(Electronic) Receipt
Aug 28, 2015
Amended claims with annotations
Aug 28, 2015
Annex
Aug 28, 2015
Claims
Aug 28, 2015
Letter accompanying subsequently filed items
Aug 28, 2015
Reply to communication from the Examining Division
Apr 30, 2015
Annex to the communication
Apr 30, 2015
Consultation by telephone/in person (with time limit)
Apr 30, 2015
Result of consultation by telephone/in person
Oct 22, 2014
(Electronic) Receipt
Oct 22, 2014
Letter accompanying subsequently filed items
Oct 22, 2014
Reply to communication from the Examining Division
Oct 13, 2014
(Electronic) Receipt
Oct 13, 2014
Amended claims with annotations
Oct 13, 2014
Annex
Oct 13, 2014
Claims
Oct 13, 2014
Letter accompanying subsequently filed items
Oct 13, 2014
Reply to communication from the Examining Division
Jun 12, 2014
Annex to the communication
Jun 12, 2014
Communication from the Examining Division
Jun 3, 2014
Examination started
Mar 19, 2014
(Electronic) Receipt
Mar 19, 2014
Amended claims with annotations
Mar 19, 2014
Claims
Mar 19, 2014
Letter accompanying subsequently filed items
Mar 19, 2014
Matter concerning the application
Jul 27, 2012
Communication of amended entries concerning the representative
Feb 29, 2012
Notification on forthcoming publication of bibliographic data
Jan 27, 2012
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Dec 19, 2011
(Electronic) Receipt
Dec 19, 2011
Amended claims filed after receipt of (European) search report
Dec 19, 2011
Amended claims with annotations
Dec 19, 2011
Amendments received before examination
Dec 19, 2011
Request for entry into the European phase
Dec 5, 2011
Copy of the international preliminary report on patentability
Sep 30, 2011
Information on entry into European phase
Dec 17, 2010
Priority document (electronically transmitted)
Nov 25, 2010
Copy of the international search report
Nov 25, 2010
Published international application - A1
Jul 28, 2010
Written opinion of the ISA, boxes No. I to VIII
Jul 28, 2010
Written opinion of the ISA, cover sheet
Jul 28, 2010
Written opinion of the ISA, supplemental box
Jun 29, 2010
Abstract
Jun 29, 2010
Claims
Jun 29, 2010
Description
Jun 29, 2010
Drawings

EP2432454

NEURODERM

Application Number: EP10725880A
Filing Date: May 17, 2010
Status: Opposition Rejected; Dec 6, 2019
Publication Date: Mar 1, 2017
External Links: Slate, Register , Google Patents

IP Verse

Compositions For Continuous Administration Of Dopa Decarboxylase Inhibitors

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2432454